Fluorodeoxyglucose positron emission tomography response and normal tissue regeneration after stereotactic body radiotherapy to liver metastases

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 5, 2012, Pages

  Stinauer, Michelle A ^a   Diot, Quentin ^a   Westerly, David C ^a   Schefter, Tracey E ^a   Kavanagh, Brian D ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Liver metastasis; PET imaging; SBRT

Indexed keywords

BASELINE LEVELS; COMPUTED TOMOGRAPHY SCAN; EXPONENTIAL DECAYS; FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHIES; LIVER METASTASIS; LIVER VOLUME; LOCAL FAILURE; NORMAL TISSUE; PET IMAGING; PET SCAN; POST TREATMENT; PRE-TREATMENT; SBRT; SOLID TUMORS; STANDARD DEVIATION; STANDARDIZED UPTAKE VALUES; STEREOTACTIC BODY RADIATION THERAPY; STEREOTACTIC BODY RADIOTHERAPY;

CURVE FITTING; NEONATAL MONITORING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOTHERAPY; TUMORS;

COMPUTERIZED TOMOGRAPHY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; LIVER WEIGHT; MALE; MEDICAL RECORD REVIEW; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIOLOGICAL PARAMETERS; STANDARDIZED UPTAKE VALUE; STEREOTACTIC BODY RADIATION THERAPY; TISSUE REGENERATION; VOLUMETRY;

ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER; LIVER NEOPLASMS; LIVER REGENERATION; MALE; MIDDLE AGED; ORGAN SIZE; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOSURGERY; TREATMENT OUTCOME;

EID: 84863622278     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.02.008     Document Type: Article

References (19)

1. D.V. Sahani, and S.P. Kalva Imaging the liver Oncologist 9 2004 385 397
2. M. Yang, D.R. Martin, and N. Karabulut Comparison of MR and PET imaging for the evaluation of liver metastases J Magn Reson Imaging 17 2003 343 349
3. K. Kinkel, Y. Lu, and M. Both Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis Radiology 224 2002 748 756
4. S. Bipat, M.S. van Leeuwen, and E.F. Comans Colorectal liver metastases: CT, MR imaging, and PET for diagnosis - meta-analysis Radiology 237 2005 123 131
5. A. Sols, and R.K. Crane The inhibition of brain hexokinase by adenosinediphosphate and sulfhydryl reagents J Biol Chem 206 1954 925 936
6. L.M. Velasquez, R. Boellaard, and G. Kollia Repeatability of 18F-FDG PET in a multicenter phase I study of patients with advanced gastrointestinal malignancies J Nucl Med 50 2009 1646 1654
7. C. Nahmias, and L.M. Wahl Reproducibility of standardized uptake value measurements determined by 18F-FDG PET in malignant tumors J Nucl Med 49 2008 1804 1808
8. D. Schellenberg, A. Quon, and A.Y. Minn 18Fluorodeoxyglucose PET is prognostic of progression-free and overall survival in locally advanced pancreas cancer treated with stereotactic radiotherapy Int J Radiat Oncol Biol Phys 77 2010 1420 1425
9. D.J. Hoopes, M. Tann, and J.W. Fletcher FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer Lung Cancer 56 2007 229 234
10. M.J. Burdick, K.L. Stephans, and C.A. Reddy Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy Int J Radiat Oncol Biol Phys 78 2010 1033 1039
11. M.A. Henderson, D.J. Hoopes, and J.W. Fletcher A pilot trial of serial 18F-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapy Int J Radiat Oncol Biol Phys 76 2010 789 795
12. T.E. Schefter, B.D. Kavanagh, and R.D. Timmerman A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases Int J Radiat Oncol Biol Phys 62 2005 1371 1378
13. K.K. Herfarth, H. Hof, and M.L. Bahner Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors Int J Radiat Oncol Biol Phys 57 2003 444 451
14. C.C. Olsen, J. Welsh, and B.D. Kavanagh Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy Int J Radiat Oncol Biol Phys 73 2009 1414 1424
15. Y. Matsuo, Y. Nakamoto, and Y. Nagata Characterization of FDG-PET images after stereotactic body radiation therapy for lung cancer Radiother Oncol 97 2010 200 204
16. C.Y. Lin, H.J. Ding, and C.C. Lin Impact of age on FDG uptake in the liver on PET scan Clin Imaging 34 2010 348 350
17. K.E. Rusthoven, B.D. Kavanagh, and H. Cardenes Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases J Clin Oncol 27 2009 1572 1578
18. K.K. Herfarth, J. Debus, and F. Lohr Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial J Clin Oncol 19 2001 164 170
19. M.F. Chen, T.L. Hwang, and C.F. Hung Human liver regeneration after major hepatectomy. A study of liver volume by computed tomography Ann Surg 213 1991 227 229